420 with CNW – Thousands Submit Comments Urging FDA to Allow CBD in Supplements and Foods
The U.S. Food and Drug Administration (FDA) started receiving comments on CBD regulation from the public and other stakeholders in April and the comments period came to an end early last week. The agency had initially planned to close the comments period on July 2 but the overwhelming public interest in the matter led the FDA to extent that deadline to July 16. By the close of the comments period, more than 4,400 submissions had been filed by individuals and organization. The comments received covered everything imaginable about the therapeutic effects of CBD, how the compound should be tested, packaged…

















